A Review of Advances Related to Serum Gastric Function Test in Diagnosis of Atrophic Gastritis and Risk Assessment of Gastric Cancer
10.3969/j.issn.1003-4706.2018.08.026
- VernacularTitle:血清胃功能检测对萎缩性胃炎诊断及胃癌风险评估的研究进展
- Author:
Ying-Rui MA
1
;
Zan ZUO
;
Qiang GUO
Author Information
1. 大理大学临床医学院
- Keywords:
Pepsinogen;
Gastrin;
Helicobacter pylori;
Atrophic gastritis;
Gastric cancer
- From:
Journal of Kunming Medical University
2018;39(8):124-128
- CountryChina
- Language:Chinese
-
Abstract:
As a recognized precancerous disease, the chronic atrophic gastritis (CAG) has a low diagnosis rate at an early stage due to its atypical symptoms. While massive studies have shown that changes in the serum gastric function parameters including pepsinogen (PG) and gastrin 17 (G17) levels which can be reflected by the functional and morphological status of the gastric mucosa, moreover, H. pylori plays a catalytic role in mucosal atrophy and intestinal metaplasia, indirectly affects the values of the above items. In this article, we discussd the progress in the diagnosis of atrophic gastritis and the risk assessment of gastric cancer based on serum gastric function tests.
